McKesson has released a new Horizon Cardiology product for the cath lab, the Holding Area Charting, designed to simplify and expedite information flow in the cath lab, increase data accuracy by minimizing duplication and strengthen the facility’s commitment to patient safety.

The Society for Cardiovascular Angiography and Interventions (SCAI) has partnered with the American College of Cardiology (ACC) to co-locate its 33rd annual meeting with the ACC.08 57th Annual Scientific Session to form the new SCAI-ACCi2 meeting.

March 18, 2008 - Abiomed Inc. received conditional approval from the FDA to begin its Impella 2.5 Circulatory Support System study in the U.S. under an investigational device exemption (IDE) for hemodynamically unstable patients undergoing a percutaneous coronary intervention (PCI) procedure due to acute myocardial infarction (AMI).

March 13, 2008 – Abbott’s fully bioabsorbable drug-eluting stent for the treatment of coronary artery disease demonstrated no stent thrombosis, no clinically driven target lesion revascularizations and a 3.3 percent rate of major adverse cardiac events (MACE) in 30 patients out to one year, according to data from the ABSORB clinical trial published in The Lancet on March 13, 2008.

March 13, 2008 - Signalife Inc. received the Frost and Sullivan 'Technology Innovation Award for North American Patient Monitoring' for its artifact reducing technology, marking the second time the company has received this award.

Frost and Sullivan gave Signalife the award for its Fidelity heart monitoring systems, which Frost and Sullivan said provides signal clarity in the wireless cardiac monitoring arena.

March 11, 2008 – The FDA cleared an investigational device exemption (IDE) application from Life Recovery Systems to use the ThermoSuit noninvasive cooling system to investigate rapid hypothermia treatment in combination with primary angioplasty to treat heart attacks.

March 11, 2008 - Mindray Medical International Ltd. signed a definitive agreement to acquire Datascope Corp.’s patient monitoring business, reportedly making Mindray the third-largest player in the global patient monitoring device industry.

Datascope’s patient monitoring business earned total revenues of $161.3 million in year 2007. The transaction is expected to be accretive to Mindray’s earnings per share on a non-GAAP basis starting in 2009.

Agfa will showcase the latest offering of its in Cardiology Data Management, IMPAX CV, focusing on the noninvasive cardiologist, working to integrate echocardiography, noninvasive Vascular (NIV), nuclear cardiology and ECG information into a complete Web-based physician reporting system.

LifeScan Inc. launched two new products to help hospitals improve execution of tight glycemic control protocols - the OneTouch TGC Advisor and OneTouch DataLink Wireless V2.

March 14, 2008 - Thirteen of the 18 top-ranked U.S. News and World Report hospitals (72.2 percent) use the noninvasive Arctic Sun device from Medivance for induced hypothermia and re-warming patients.

Medivance said this week 16 of the top 20 heart programs (80 percent) and 16 of the top 20 neurology programs cool and re-warm patients with the automated Arctic Sun device.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now